This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In “Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson Disease: A Longitudinal Cohort Study,” Becker et al. report that while 40% of 268 patients with Parkinson disease (PD) had mild cognitive impairment (MCI) at baseline, of 164 patients who completed follow-up after 3.78 ± 0.84 years, 33% had MCI and 10% had dementia. Patients in this study were evaluated using the Functional Activities Questionnaire (FAQ) to differentiate cognitive and motor contributions to impairment in performance of instrumental activities of daily living (IADL). Kasten questions how the results of the FAQ compared with results of the Montreal Cognitive Assessment (MoCA) and whether these scores could be used interchangeably. Dr. Kasten also cites a prior study that found that the Unified Parkinson Disease Rating Scale was moderately correlated with the MoCA. Becker reports there was a weak to moderate correlation between FAQ and MoCA scores at both baseline and follow-up. However, although there is some overlap between these assessments, Becker does not believe they should be used interchangeably because MoCA measures general cognition while the FAQ measures cognitive contributions to IADL impairment. This exchange highlights important methodological considerations when screening for cognitive decline in PD.
In “Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson Disease: A Longitudinal Cohort Study,” Becker et al. report that while 40% of 268 patients with Parkinson disease (PD) had mild cognitive impairment (MCI) at baseline, of 164 patients who completed follow-up after 3.78 ± 0.84 years, 33% had MCI and 10% had dementia. Patients in this study were evaluated using the Functional Activities Questionnaire (FAQ) to differentiate cognitive and motor contributions to impairment in performance of instrumental activities of daily living (IADL). Kasten questions how the results of the FAQ compared with results of the Montreal Cognitive Assessment (MoCA) and whether these scores could be used interchangeably. Dr. Kasten also cites a prior study that found that the Unified Parkinson Disease Rating Scale was moderately correlated with the MoCA. Becker reports there was a weak to moderate correlation between FAQ and MoCA scores at both baseline and follow-up. However, although there is some overlap between these assessments, Becker does not believe they should be used interchangeably because MoCA measures general cognition while the FAQ measures cognitive contributions to IADL impairment. This exchange highlights important methodological considerations when screening for cognitive decline in PD.
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- Received December 20, 2022.
- Accepted in final form December 20, 2022.
- © 2023 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
